Received: 3 December 2021
Accepted: 23 November 2022
First Online: 12 December 2022
: The study was approved by the National Research Ethics Committee (N° 201.505/12) and the National Commission for Private Data Protection (CNPD). All participants were informed about the study details and signed an informed consent.
: Not applicable.
: AB, GA and LM declare that they have no competing interests. GF has received consulting fees from Lilly, MSD, Roche Diabetes Care, AstraZeneca, Diabeloop and Danone Research. DEF is supported by a doctoral grant from the French National Cancer Institute (INCa_13563).